This discussion has been published as a research paper
TDX-2026-00015
Approach to FUO in immunocompetent adult after standard workup is negative?
42F with fever > 38.3°C for 4 weeks, no diagnosis despite comprehensive initial workup. She has lost 5 kg, has night sweats, but no localizing symptoms.
Completed workup (all negative or non-diagnostic):
- Blood cultures x3 (negative)
- Urine culture (negative)
- Chest X-ray (normal)
- CT abdomen/pelvis (normal)
- HIV, hepatitis B/C (negative)
- ANA, RF, anti-dsDNA (negative)
- ESR 68, CRP 4.2
- Peripheral smear (no blasts, no atypical cells)
- Quantiferon TB Gold (negative)
- Echocardiogram (normal, no vegetations)
Questions:
- What is your next-tier workup at this point?
- Role of PET-CT in FUO?
- When do you empirically start anti-TB treatment in endemic areas despite negative Quantiferon?
- How long do you observe before considering empiric steroids for possible adult-onset Still's disease?
2 Answers
This is a classic ID consult scenario. Here is my systematic second-tier approach:
1. Next-tier workup:
- FDG PET-CT (see below)
- Ferritin (if >1000, adult-onset Still's disease jumps to top of differential)
- LDH, uric acid, beta-2 microglobulin (occult lymphoma screen)
- Serum protein electrophoresis (myeloma screen)
- Repeat blood cultures (specifically for HACEK organisms, which are slow-growing; hold cultures for 14 days)
- Bone marrow biopsy with cultures, AFB stain, and flow cytometry
- Temporal artery biopsy if patient is > 50 (giant cell arteritis presents as FUO in 15% of cases; your patient is 42, borderline)
- Liver biopsy if any hepatic abnormality on imaging or labs
2. PET-CT in FUO: This is the single most useful second-tier investigation. A systematic review by Bharucha et al. (2017) showed PET-CT identifies the cause of FUO in approximately 50% of cases where conventional workup is negative. The most common findings: occult abscess, large-vessel vasculitis, lymphoma, and granulomatous disease. I order PET-CT before invasive biopsies because it can direct where to biopsy.
3. Empiric anti-TB in endemic areas: In India, this is a real dilemma. Quantiferon has a sensitivity of 80 to 90% for active TB; it can miss cases, especially extrapulmonary TB. I consider empiric anti-TB if: all other workup is negative, the patient has risk factors (exposure history, prior TB, immunosuppression), and there is any imaging finding suggestive of granulomatous disease (mediastinal lymphadenopathy, hepatic granulomas). I do NOT empirically treat TB based solely on fever and weight loss in the setting of a negative Quantiferon without supporting evidence.
4. Empiric steroids for Still's: I require ferritin > 1000, a classic quotidian fever pattern (spikes to > 39°C once or twice daily with return to baseline), evanescent salmon-colored rash, and negative infectious workup before considering empiric steroids. Even then, I prefer a skin biopsy of the rash (if present) to confirm the diagnosis before immunosuppression.